Idiopathic inflammatory myopathies

Best Practice and Research: Clinical Rheumatology

Volumn 26, Issue 1, 2012, Pages 25-45

  Vincze, Melinda ^a   Danko, Katalin ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Cancer associated myositis; Dermatomyositis; Inclusion body myositis; Necrotising myopathy; Polymyositis

Indexed keywords

ALAFACEPT; ALEMTUZUMAB; ALLOPURINOL; AUTOANTIBODY; AUTOANTIGEN; AZATHIOPRINE; COMPLEMENT; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOKINE; ECULIZUMAB; EFALIZUMAB; HLA B8 ANTIGEN; HLA DQA1 ANTIGEN; HLA DR3 ANTIGEN; HLA DRB1 ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; JO 1 ANTIBODY; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; MYOSITIS ASSOCIATED AUTOANTIBODY; PREDNISONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RITUXIMAB; SIGNAL RECOGNITION PARTICLE; TACROLIMUS; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADENOVIRUS; ALOPECIA; ANEMIA; ANTIGEN EXPRESSION; ARTHRALGIA; ARTHRITIS; ASPIRATION PNEUMONIA; ATELECTASIS; BLEEDING; BONE MARROW DEPRESSION; CANCER ASSOCIATED MYOSITIS; CANCER DIAGNOSIS; CASE CONTROL STUDY; CLINICAL EXAMINATION; COLORECTAL CANCER; CONCENTRATION (PARAMETERS); CONGESTIVE HEART FAILURE; COR PULMONALE; CORTICOSTEROID THERAPY; COXSACKIE VIRUS B; CYSTITIS; DAILY LIFE ACTIVITY; DERMATITIS; DERMATOMYOSITIS; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG EXPOSURE; DRUG MECHANISM; DRUG METABOLISM; DRUG TOLERABILITY; DYSPHAGIA; DYSPNEA; ECHO VIRUS; EDEMA; ELECTROMYOGRAM; ENVIRONMENTAL FACTOR; ERYTHEMA; FATIGUE; FEVER; FIBROSING ALVEOLITIS; GASTROINTESTINAL REFLUX; GASTROINTESTINAL SYMPTOM; GENE FREQUENCY; GENE REARRANGEMENT; GENETIC RISK; HEART ARRHYTHMIA; HEMATOLOGIC MALIGNANCY; HEPATITIS B VIRUS; HEREDITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMORAL IMMUNITY; HYPOXIA; IDIOPATHIC DISEASE; IDIOPATHIC INFLAMMATORY MYOPATHY; IMMUNE DEFICIENCY; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INCLUSION BODY MYOSITIS; INFLUENZA VIRUS; INTESTINAL DYSMOTILITY; LEUKOPENIA; LIVER TOXICITY; LUNG CANCER; LYMPHOMA; MALAISE; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE CONTRACTURE; MUSCLE STRENGTH; MUSCLE WEAKNESS; MYALGIA; MYOCARDITIS; MYOPATHY; NAUSEA; NECROTISING AUTOIMMUNE MYOSITIS; ONSET AGE; OVARY CANCER; PANCREAS CANCER; PANCYTOPENIA; PAPULE; PATIENT CARE PLANNING; PHENOTYPE; PHOTOSENSITIVITY; PHYSIOTHERAPY; PNEUMONIA; POLYMYOSITIS; PRIORITY JOURNAL; PROGNOSIS; PRURITUS; QUALITY OF LIFE; RASH; RAYNAUD PHENOMENON; REVIEW; RHABDOMYOLYSIS; RISK ASSESSMENT; SCLERODERMA; SECONDARY MALIGNANCY; SEROLOGY; SEX RATIO; SJOEGREN SYNDROME; SKIN CALCIFICATION; SMALL VESSEL VASCULITIS; SMOKING; STERILITY; STOMACH CANCER; STOMATITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; TH1 TH2 BALANCE; THROMBOCYTOPENIA; TOXOPLASMA; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT RESPONSE; ULCER; ULTRAVIOLET B RADIATION; VOMITING; WEIGHT REDUCTION;

HUMANS; MYOSITIS;

EID: 84858376034     PISSN: 15216942     EISSN: 15321770     Source Type: Journal    
DOI: 10.1016/j.berh.2012.01.013     Document Type: Review

References (86)

1. P.H. Plotz, L.G. Rider, I.N. Targoff, N. Raben, T.P. O'Hanlon, and F.W. Miller NIH Conference, myositis: immunologic contributions to understanding cause, pathogenesis, and therapy Annals of Internal Medicine 122 1995 715 724
2. A. Bohan, and J.B. Peter Polymyositis and dermatomyositis New England Journal of Medicine 292 1975 344 407 és 403-407
3. G.L. Rider, and W.F. Miller Idiopathic inflammatorymuscle disease: clinical aspects Balliere's Clinical Rheumatology 14 2000 37 54
4. M.C. Dalakas, and R. Hohlfeld Polymyositis and dermatomyositis Lancet 362 2003 971 982 (Pubitemid 37159295)
5. C. Dorph, and I.E. Lundberg Idiopathic inflammatory myopathies - myositis Best Practice and Research Clinical Rheumatology 16 5 2002 Dec 817 832 [Review]
6. F.W. Miller, L.G. Rider, P.H. Plotz, S.B. Rutkove, A. Pestronk, and R.L. Wortmann Polymyositis: an overdiagnosed entity Neurology 63 2 2004 Jul27 402
7. S. Zampieri, A. Ghirardello, L. Iaccarno, P.F. Gambari, and A. Doria Infections and polymyositis-dermatomyositis. Infection and autoimmunity 2004 Elsevier BV Amsterdam pp. 583-590
8. S. Okada, E. Weatherhead, I.N. Targoff, R. Wesley, and F.W. Miller Global surface ultraviolet radiation intensity may modulate the clinical and immunologic expression of autoimmune muscle disease Arthritis & Rheumatism 48 2003 2285 2293 (Pubitemid 36959210)
9. th. Dec.2011.
10. Dankó K, Czirják L. Clinical immunology. Medicina Könyvkiadó Zrt; 2010 (book) 38-45; 70; 178-190.
11. M.C. Dalakas Immunopathogenesis of inflammatory myopathies Annals of Neurology 37 Suppl. 1 1995 S74 S86
12. M.C. Dalakas Mechanisms of disease: signaling pathways and immunobiology of inflammatory myopathies Nature Clinical Practice Rheumatology 2 2006 219 227
13. K. Arahata, and A.G. Engel Monoclonal antibody analysis of mononuclear cells in myopathies. I: quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells Annals of Neurology 16 1984 193 208 (Pubitemid 14062666)
14. K. Arahata, and A.G. Engel Monoclonal antibody analysis of mononuclear cells in myopathies. III: immunoelectron microscopy aspects of cell-mediated muscle fiber injury Annals of Neurology 19 1986 112 125 (Pubitemid 16114164)
15. N. Goebels, D. Michaelis, M. Engelhardt, S. Huber, A. Bender, and D. Pongratz Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis Journal of Clinical Investigation 97 1996 2905 2910 (Pubitemid 26197106)
16. A. Bender, N. Ernst, A. Iglesias, K. Dornmair, H. Wekerle, and R. Hohlfeld T cell receptor repertoire in polymyositis: clonal expansion of autoaggressive CD8 T cells Journal of Experimental Medicine 181 1995 1863 1868
17. A.G. Engel, and K. Arahata Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies Human Pathology 17 1986 704 721 (Pubitemid 16070409)
18. K. Amemiya, R.P. Granger, and M.C. Dalakas Clonal restriction of T-cell receptor expression by infiltrating lymphocytes in inclusion body myositis persists over time. Studies in repeated muscle biopsies Brain 123 Pt 10 2000 2030 2039
19. M. Hofbauer, S. Wiesener, H. Babbe, A. Roers, H. Wekerle, and K. Dornmair Clonal tracking of autoaggressive T cells in polymyositis by combining laser microdissection, single-cell PCR, and CDR3-spectratype analysis Proceedings of the National Academy of Sciences of the United States of America 100 2003 4090 4095 (Pubitemid 36418162)
20. J.T. Kissel, J.R. Mendell, and K.W. Rammohan Microvascular deposition of complement membrane attack complex in dermatomyositis New England Journal of Medicine 314 1986 329 334 (Pubitemid 16166259)
21. A.M. Emslie-Smith, and A.G. Engel Microvascular changes in early and advanced dermatomyositis: a quantitative study Annals of Neurology 27 1990 343 356 (Pubitemid 20132049)
22. M. Civatte, C. Bartoli, N. Schleinitz, B. Chetaille, J.F. Pellissier, and D. Frigarella-Branger Expression of the beta chemokines CCL3, CCL4, CCL5 and their receptors in idiopathic inflammatory myopathies Neuropathology and Applied Neurobiology 31 2005 70 79 (Pubitemid 40222827)
23. I. Illa, E. Gallardo, R. Gimeno, C. Serrano, I. Ferrer, and C. Juárez Signal transducer and activator of transcription 1 in human muscle: implications in inflammatory myopathies American Journal of Pathology 151 1997 81 88
24. C.M. López de Padilla, A.N. Vallejo, K.T. McNallan, R. Vehe, S.A. Smith, and A.B. Dietz Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis Arthritis & Rheumatism 56 2007 1658 1668 (Pubitemid 46764095)
25. D.S. Tews, and H.H. Goebel Expression of cell adhesion molecules in inflammatory myopathies Journal of Neuroimmunology 59 1995 185 194
26. J.L. De Bleecker, and A.G. Engel Expression of cell adhesion molecules in inflammatory myopathies and Duchenne dystrophy Journal of Neuropathology & Experimental Neurology 53 1994 369 376 (Pubitemid 24216036)
27. M.C. Dalakas Molecular immunology and genetics of inflammatory muscle diseases Archives of Neurology 55 12 1998 Dec 1509 1512
28. F.C. Arnett, I.N. Targoff, T. Mimori, R. Goldstein, N.B. Warner, and J.D. Reveille Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis Arthritis & Rheumatism 39 1996 1507 1518 (Pubitemid 26314984)
29. J.M. Friedman, L.M. Pachman, M.L. Maryjowski, O. Jonasson, N.D. Battles, and W.E. Crowe Immunogenetic studies of juvenile dermatomyositis: HLA antigens in patients and their families Tissue Antigens 21 1983 45 49 (Pubitemid 13180486)
30. T. Furuya, M. Hakoda, K. Higami, H. Ueda, N. Tsuchiya, and K. Tokunaga Association of HLA class I and class II alleles with myositis in Japanese patients Journal of Rheumatology 25 1998 1109 1114 (Pubitemid 28350884)
31. L.R. Ginn, J.P. Lin, P.H. Plotz, S.J. Bale, R.L. Wilder, and A. Mbauya Familial autoimmunity in pedigrees of idiopathic inflammatory myopathy patients suggests common genetic risk factors for many autoimmune diseases Arthritis & Rheumatism 41 1998 400 405 (Pubitemid 28128763)
32. I. Hausmanowa-Petrusewicz, E. Kowalska-Oledzka, F.W. Miller, M. Jarzabek-Chorzelska, and I.N. Targoff Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies Arthritis & Rheumatism 40 1997 1257 1266 (Pubitemid 27430137)
33. R.C. Hennekam, I. Hiemstra, F.G. Jennekens, and W. Kuis Juvenile dermatomyositis in first cousins New England Journal of Medicine 323 1990 199 (letter) (Pubitemid 20219963)
34. M. Hirakata, T. Mimori, M. Akizuki, J. Craft, J.A. Hardin, and M. Homma Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in Japanese patients with inflammatory muscle disease Arthritis & Rheumatism 35 1992 449 456
35. S. Jablonska, and M. Blaszczyk Scleromyositis: a scleroderma/polymyositis overlap syndrome Clinical Rheumatology 17 1998 465 467
36. J.A. Lambie, and I.F. Duff Familial occurrence of dermatomyositis case reports and a family survey Annals of Internal Medicine 59 1963 839 847
37. C. Marguerie, C.C. Bunn, J. Copier, R.M. Bernstein, J.M. Gilroy, and C.M. Black The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-Scl Medicine (Baltimore) 71 1992 327 336
38. F.W. Miller Humoral immunity and immunogenetics in the idiopathic inflammatory myopathies Current Opinion in Rheumatology 3 1991 902 910
39. L.G. Rider, L.C. Gurley, J.P. Pandey, I. Garcie de la Torre, A.E. Kalovidouris, and T.P. O'Hanlon Clinical, serologic and immunogenetic features of familial idiopathic inflammatory myopathy Arthritis & Rheumatism 41 1998 710 719 (Pubitemid 28214990)
40. L.G. Rider, E. Shamim, S. Okada, J.P. Pandey, I.N. Targoff, and T.P. O'Hanlon Genetic risk and protective factors for idiopathic inflammatory myopathy in Koreans and American whites: a tale of two loci Arthritis & Rheumatism 42 1999 1285 1290 (Pubitemid 29268968)
41. E. Shamim, and F.W. Miller Familial autoimmunity and the idiopathic inflammatory myopathies Current Rheumatology Reports 2 2000 201 211
42. J.E. West, and A.M. Reed Analysis of HLA-DM polymorphism in juvenile dermatomyositis (JDM) patients Human Immunology 60 1999 255 258 (Pubitemid 29202513)
43. A.M. Reed, L. Pachman, and C. Ober Molecular genetic studies of major histocompatibility complex genes in children with juvenile dermatomyositis: increased risk associated with HLA-DQA1 (*)501 Human Immunology 32 1991 235 240
44. M.C. Dalakas Pathogenesis and therapies of immune-mediated myopathies Autoimmunity Reviews 2011 May 18 [Epub ahead of print]
45. L.A. Love, S.H. Burgess, and P.C. Hill Geographical and seasonal clustering in the onset of idiopathic inflammatory myopathy in groups defined by myositis specific autoantibodies Arthritis & Rheumatism 34 Suppl. 1992 S40 [Abstract]
46. I.N. Targoff Update on myositis-specific and myositis-associated autoantibodies Current Opinion in Rheumatology 12 2000 475 481
47. R.L. Leff, S.H. Burgess, F.W. Miller, L.A. Love, I.N. Targoff, and M.C. Dalakas Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy patients with anti-Jo-1 and anti-signal recognition particle autoantibodies Arthritis & Rheumatism 34 1991 1390 1396
48. L.A. Love, R.L. Leff, D.D. Fraser, I.N. Targoff, M. Dalakas, and P.H. Plotz A new approach to the classification of idiopathic inflammatory myopathy: myositisspecific autoantibodies define useful homogenous patient group Medicine 70 1991 360 374
49. F.W. Miller Myositis-specific autoantibodies Journal of the American Medical Association 270 1993 1846 1849
50. I.N. Targoff Autoantibodies to aminoacyl-transfer RNA synthetases for isoleucine and glycine. Two additional synthetases are antigenic in myositis Journal of Immunology 144 1990 1737 1743 (Pubitemid 20094004)
51. M. Hirakata, A. Suwa, S. Nagai, M.A. Kron, E.P. Trieu, and T. Mimori Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease Journal of Immunology 162 1999 2315 2320 (Pubitemid 29288856)
52. L. Hashish, E.P. Trieu, and P. Sadanandan Identification of autoantibodies to tyrosyl-tRNA synthetase in dermatomyositis with features consistent with antisynthetase syndrome [abstract] Arthritis & Rheumatism 52 2005 S312
53. Z. Betteridge, H. Gunawardena, J. North, J. Slinn, and N. McHugh Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia Rheumatology 46 2007 1005 1008 (Pubitemid 47062512)
54. S. Sato, M. Hirakata, M. Kuwana, K. Nakamura, A. Suda, and S. Inada Clinical characteristics of Japanese patients with anti-PL-7 (antithreonyl-tRNA synthetase) autoantibodies Clinical and Experimental Rheumatology 23 2005 609 615 (Pubitemid 41300701)
55. Y. Yamasaki, H. Yamada, T. Nozaki, G. Akaoqi, C. Nicols, and R. Lyons Unusually high frequency of autoantibodies to PL-7 associated with milder muscle disease in Japanese patients with polymyositis/dermatomyositis Arthritis & Rheumatism 54 2006 2004 2009 (Pubitemid 43877951)
56. B. Hervier, Y. Uzunhan, E. Hachulla, O. Benveniste, H. Nunes, and P. Delaval Antisynthetase syndrome positive for anti-threonyl-tRNA synthetase (anti-PL7) antibodies European Respiratory Journal 37 2011 714 717
57. Labirua-Iturburu A, Selva-O'Callaghan A, Dankó K, Vincze M, Vencovsky J, Charles PJ, et al. ANTI-PL-7 (ANTI-THREONYL-tRNA SYNTHETASE) ANTISYNTHETASE SYNDROME Clinical Manifestations in a Series of Patients from a European Multicenter Study (EUMYONET) and Review of the Literature, Medicine (Baltimore), in press.
58. C.V. Oddis, Y. Okano, W.A. Rudert, M. Trucco, R.J. Duquesnoy, and T.A. Medsger Jr. Serum autoantibody to the nucleolar antigen PM-Scl Arthritis & Rheumatism 10 1992 1211 1217
59. M. Reichlin, P.J. Maddison, I. Targoff, T. Bunch, F. Arnett, and G. Sharp Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromes Journal of Clinical Immunology 4 1984 40 44 (Pubitemid 14171040)
60. Y. Yamanishi, M. Maeda, S. Katayama, S. Ishioka, and M. Yamakido Scleroderma-polymyositis overlap syndrome associated with anti-Ku antibody and rimmed vacuole formation Journal of Rheumatology 23 1996 1991 1994 (Pubitemid 26376130)
61. R. Brouwer, G. Hengstman, W. Egberts, H. Ehrfeld, B. Bozic, and A. Ghirardello Autoantibody profiles in the sera of European patients with myositis Annals of the Rheumatic Diseases 60 2001 116 123 (Pubitemid 32102201)
62. C. András, A. Ponyi, T. Constantin, Z. Csiki, E. Szekanecz, and P. Szodoray Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study Journal of Rheumatology 35 2008 438 444 (Pubitemid 351374417)
63. Y.J. Chen, C.Y. Wu, and J.L. Shen Predicting factors of malignancy in dermatomyositis and polymyositis: a case control study British Journal of Dermatology 144 2001 825 831
64. S.M. Levine Cancer and myositis: new insights into an old association Current Opinion in Rheumatology 18 6 2006 Nov 620 624 [Review] (Pubitemid 44607417)
65. V. Madan, H. Chinoy, C.E. Griffiths, and R.G. Cooper Defining cancer risk in dermatomyositis Part I. Clinical and Experimental Dermatology 34 4 2009 Jun 451 455 [Epub 2009 Apr 14. Review]
66. V. Madan, H. Chinoy, C.E. Griffiths, and R.G. Cooper Defining cancer risk in dermatomyositis. Part II. Assessing diagnostic usefulness of myositis serology Clinical and Experimental Dermatology 34 5 2009 Jul 561 565 [Review]
67. P.J. Charles, and R.N. Maini The clinical implications of autoantibody detection in rheumatology Journal of the Royal College of Physicians of London 27 4 1993 Oct 358 362 [Review] (Pubitemid 23325103)
68. Z.E. Betteridge, H. Gunawardena, and N.J. McHugh Novel autoantibodies and clinical phenotypes in adult and juvenile myositis Arthritis Research and Therapy 13 2 2011 Mar18 209
69. I.E. Lundberg, and H. Alexanderson Technology insight: tools for research, diagnosis and clinical assessment of treatment in idiopathic inflammatory myopathies Nature Reviews Rheumatology 3 May 2007 282 290 (Pubitemid 46711475)
70. K. Dankó, A. Ponyi, T. Constantin, G. Borgulya, and G. Szegedi Long-term survival of patients with idiopathic inflammatorymyopathies according to clinical features: a longitudinal study of 162 cases Medicine 83 2004 35 42 (Baltimore) (Pubitemid 38124854)
71. A. Ponyi, G. Borgulya, T. Constantin, A. Váncsa, L. Gergely, and K. Dankó Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis Rheumatology 44 2005 83 88 (Oxford) (Pubitemid 40124337)
72. F.W. Miller, L.G. Rider, Y.L. Chung, R. Cooper, K. Dankó, and V. Farewell Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies Rheumatology 40 2001 1262 1273
73. A. Airio, H. Kautiainen, and M. Hakala Prognosis and mortality of polymyositis and dermatomyositis patients Clinical Rheumatology 25 2006 234 239 (Pubitemid 43372323)
74. J. Benbassat, D. Gefel, K. Larholt, S. Sukenik, V. Morgenstern, and A. Zlotnick Prognostic factors in polymyositis/dermatomyositis. A computer-assisted analysis of ninety-two cases Arthritis & Rheumatism 28 1985 249 255 (Pubitemid 15133568)
75. I. Lundberg, and Y.L. Chung Treatment and investigation of idiopathic inflammatory myopathies Rheumatology 39 2000 7 17 (Pubitemid 30095401)
76. L.G. Rider, and F.W. Miller Classification and treatment of the juvenile idiopathic inflammatory myopathies Rheumatic Disease Clinics of North America 23 1997 619 655 (Pubitemid 27397123)
77. L. Villalba, and E.M. Adams Update on therapy for refractory dermatomyositis and polymyositis Current Opinion in Rheumatology 8 1996 544 551 (Pubitemid 27044443)
78. E. Lundberg Ingrid, and A. Nader Gustavo Molecular effects of exercise in patients with inflammatory rheumatic disease Nature Clinical Practice Rheumatology 4 11 2008 Nov 597 604
79. H. Wiendl, R. Hohlfeld, and B.C. Kieseier Immunobiology of muscle: advances in understanding and immunological microenvironment Trends in Immunology 26 2005 373 380 (Pubitemid 40835843)
80. M.C. Dalakas Intravenous immunoglobulin in autoimmune neuromuscular diseases Journal of the American Medical Association 291 2004 2367 2375 (Pubitemid 38656304)
81. T.D. Levine Rituximab in the treatment of dermatomyositis: an open-label pilot study Arthritis & Rheumatism 52 2005 601 607 (Pubitemid 40216325)
82. L. Chung, M.C. Genovese, and D.F. Fiorentino A pilot trial of rituximab in the treatment of patients with dermatomyositis Archives of Dermatology 143 2007 763 767 (Pubitemid 46955736)
83. Z. Kaposztas, W.B. Etheridge, and B.D. Kahan Case report: successful treatment of posttransplant lymphoproliferative disorder and quiescence of dermatomyositis with rituximab and sirolimus Transplantation Proceedings 40 2008 1744 1746 (Pubitemid 351853149)
84. H. Alexanderson, and I.E. Lundberg The role of exercise in the rehabilitation of idiopathic inflammatory myopathies Current Opinion in Rheumatology 17 2005 164 171 (Pubitemid 40279612)
85. A. Váncsa, and K. Dankó Inclusion body myositis pathomechanism and therapy Orvosi Hetilap 149 2008 1413 1418 [Hungarian]
86. K. Dankó, and M. Vincze New therapeutic approaches for polymyositis and dermatomyositis Orvosi Hetilap 152 39 2011 Sep25 1552 1559 [Hungarian]